Akari Therapeutics PLC (AKTX) — Cash Flow-to-Debt Ratio
Akari Therapeutics PLC (AKTX) has a Cash Flow-to-Debt Ratio of -0.16x as of December 2025, meaning its operating cash flow of $-3.04 Million could theoretically repay 0% of its total liabilities ($19.56 Million) in one year. See Akari Therapeutics PLC (AKTX) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Akari Therapeutics PLC Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for Akari Therapeutics PLC across 16 annual periods. For the full cash flow conversion analysis, see how efficiently does Akari Therapeutics PLC generate cash.
Annual Cash Flow-to-Debt Ratio for Akari Therapeutics PLC (2010–2025)
Year-by-year debt coverage analysis for Akari Therapeutics PLC. Check cash flow quality index of Akari Therapeutics PLC to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.54x | $-10.57 Million | $19.56 Million | ▼ -21.9% |
| 2024 | -0.44x | $-12.55 Million | $28.33 Million | ▲ +87.6% |
| 2023 | -3.58x | $-16.43 Million | $4.58 Million | ▼ -100.7% |
| 2022 | -1.79x | $-21.50 Million | $12.04 Million | ▲ +42.3% |
| 2021 | -3.09x | $-18.85 Million | $6.09 Million | ▲ +4.7% |
| 2020 | -3.25x | $-16.95 Million | $5.22 Million | ▼ -62.6% |
| 2019 | -2.00x | $-12.92 Million | $6.47 Million | ▲ +72.8% |
| 2018 | -7.33x | $-22.54 Million | $3.08 Million | ▼ -110.3% |
| 2017 | -3.48x | $-31.60 Million | $9.07 Million | ▼ -66.5% |
| 2016 | -2.09x | $-24.62 Million | $11.77 Million | ▼ -792.0% |
| 2015 | -0.23x | $-4.97 Million | $21.17 Million | ▲ +96.0% |
| 2014 | -5.81x | $-9.46 Million | $1.63 Million | ▼ -115.3% |
| 2013 | -2.70x | $-5.45 Million | $2.02 Million | ▼ -467.0% |
| 2012 | -0.48x | $-2.13 Million | $4.48 Million | ▼ -18.7% |
| 2011 | -0.40x | $-1.01 Million | $2.51 Million | ▼ -126.2% |
| 2010 | -0.18x | $-366.00K | $2.06 Million | — |